Systematic analysis of markers for T‐cell differentiation revealing CD95 as a novel biomarker for prognosis and immunotherapeutic efficacy in colon cancer
Main Authors: | Yuxin Shi, Jie Mei, Rui Hou, Hao Wang, Junli Ding, Junying Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-12-01
|
Series: | MedComm – Oncology |
Online Access: | https://doi.org/10.1002/mog2.57 |
Similar Items
-
Cuproplasia characterization in colon cancer assists to predict prognosis and immunotherapeutic response
by: Bomiao Zhang, et al.
Published: (2023-03-01) -
Identification and verification of PTPN3 as a novel biomarker in predicting cancer prognosis, immunity, and immunotherapeutic efficacy
by: Ziting Zhou, et al.
Published: (2024-01-01) -
CD70 in Thymic Squamous Cell Carcinoma: Potential Diagnostic Markers and Immunotherapeutic Targets
by: Jumpei Kashima, et al.
Published: (2022-01-01) -
CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis
by: Shuangqing Liu, et al.
Published: (2023-06-01) -
Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity
by: Yanlin Wu, et al.
Published: (2023-06-01)